Table 4 Multivariate Cox regression analysis of progression-free survival and overall survival
From: The prognostic significance of BAP1, NF2, and CDKN2A in malignant peritoneal mesothelioma
Patient or tumor characteristics | Progression-free survival HR (95% CI) | P-value | Overall survival HR (95% CI) | P-value |
|---|---|---|---|---|
Age, ≥60 years vs <60 years | 2.12 (1.20–3.75) | 0.010 | 2.66 (1.39–5.09) | 0.003 |
Peritoneal cancer index | 1.07 (1.02–1.12) | 0.004 | 1.07 (1.01–1.14) | 0.025 |
CC score, 2 to 3 vs 0 to 1 | — | — | 1.41 (0.66–3.00) | 0.373 |
Extent of invasion, viscera vs fat | 1.95 (1.11–3.42) | 0.020 | 2.32 (1.23–4.39) | 0.010 |
CDKN2A and NF2, combined deletion/loss vs not | 2.38 (1.15–4.94) | 0.019 | 4.7 (1.76–9.39) | 0.001 |
